[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.176.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
May 14, 2003

Cholinesterase Inhibitors for Alzheimer DiseaseCholinesterase Inhibitors for Alzheimer Disease

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;289(18):2359. doi:10.1001/jama.289.18.2359-a

To the Editor: Dr Trinh and colleagues1 concluded that ChIs have a "modest" beneficial role in treating neuropsychiatric symptoms. Their results do not support these claims.

The trials included in the meta-analysis did not include patients with significant behavioral symptomatology. They were designed to enroll mildly to moderately impaired patients who could complete cognitive testing and who had no significant behavioral problems. Furthermore, some allowed use of various psychotropic medications, thereby potentially confounding the results.

First Page Preview View Large
First page PDF preview
First page PDF preview
×